Search hospitals > Wisconsin > Johnson Creek
UW Cancer Center Johnson Creek
Claim this profileJohnson Creek, Wisconsin 53038
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Prostate Cancer
Conducts research for Skin Cancer
121 reported clinical trials
20 medical researchers
Summary
UW Cancer Center Johnson Creek is a medical facility located in Johnson Creek, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Skin Cancer and other specialties. UW Cancer Center Johnson Creek is involved with conducting 121 clinical trials across 182 conditions. There are 20 research doctors associated with this hospital, such as Kenneth B. De Santes, Nataliya V. Uboha, Kari B. Wisinski, and Ticiana A. Leal.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderER positive
HER2 positive
HER2 negative
Top PIs
Kenneth B. De SantesUniversity of Wisconsin Carbone Cancer Center7 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
57 reported clinical trials
104 drugs studied
Nataliya V. UbohaUniversity of Wisconsin Carbone Cancer Center5 years of reported clinical research
Studies Tumors
Studies Cancer
20 reported clinical trials
54 drugs studied
Kari B. WisinskiUniversity of Wisconsin Carbone Cancer Center6 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
18 reported clinical trials
49 drugs studied
Ticiana A. LealUniversity of Wisconsin Hospital and Clinics4 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
16 reported clinical trials
23 drugs studied
Clinical Trials running at UW Cancer Center Johnson Creek
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Squamous Cell Carcinoma
Cancer
Ovarian Tumors
Gastric Cancer
Esophageal Adenocarcinoma
Pancreatic Carcinoma
Anal Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UW Cancer Center Johnson Creek?
UW Cancer Center Johnson Creek is a medical facility located in Johnson Creek, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Skin Cancer and other specialties. UW Cancer Center Johnson Creek is involved with conducting 121 clinical trials across 182 conditions. There are 20 research doctors associated with this hospital, such as Kenneth B. De Santes, Nataliya V. Uboha, Kari B. Wisinski, and Ticiana A. Leal.